Company intelligence / Profile preview

Emerillon Capital

Montréal, Québec, Canada

Ownership: Private
Development stage: Other

Overview

Emerillon Capital is a $100M venture capital fund founded in 2013, based in Montreal, specializing in equity investments ($0.5M-$5M) in early-stage tech companies. Its focus areas include health/medical, information technology, and clean tech, with an investment term of 7-9 years.

Industry: Investors

Partnerships

Fonds de solidarité FTQC2MIDebiopharm GroupSanderling VenturesArix Bioscience

Beyond the preview

Go deeper on Emerillon Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emerillon Capital.

Explore the full profile